SEC Comment Letter 0000000000-23-000693 to GUIDED THERAPEUTICS INC (GTHP) (CIK 0000924515) (GTHP)

GUIDED THERAPEUTICS INC (GTHP) (CIK 0000924515)
Date: Jan. 23, 2023 · CIK: 0000924515 · Accession: 0000000000-23-000693

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-269229

Date

January 23, 2023

Author

Not clearly detected

Form

UPLOAD

Company

GUIDED THERAPEUTICS INC (GTHP) (CIK 0000924515)

Letter

United States securities and exchange commission logo January 23, 2023 Gene S. Cartwright Chief Executive Officer Guided Therapeutics, Inc. 5835 Peachtree Corners East, Suite B Norcross, Georgia 30092 Re:Guided Therapeutics, Inc. Registration Statement on Form S-1 Filed January 13, 2023 File No. 333-269229 Dear Gene S. Cartwright: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Justin Grossman

Show Raw Text

United States securities and exchange commission logo
January 23, 2023
Gene S. Cartwright
Chief Executive Officer
Guided Therapeutics, Inc.
5835 Peachtree Corners East, Suite B
Norcross, Georgia 30092
Re:Guided Therapeutics, Inc.
Registration Statement on Form S-1
Filed January 13, 2023
File No. 333-269229
Dear Gene S. Cartwright:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Justin Grossman

SecProbe.io